Table 3.
|
cT1, (n = 143)
|
MR liver fat (n = 143)
|
MRE (n = 144)
|
VCTE-LSM (n = 117)
|
CAP (n = 117)
|
2D SWE (n = 84)
|
Fibrosis | 0.24, P < 0.01 | -0.25, P <0.01 | 0.75, P < 0.001 | 0.69, P < 0.001 | 0.05, P = 0.58 | 0.72, P < 0.001 |
Steatosis | 0.29, P < 0.001 | 0.70, P < 0.001 | -0.23, P < 0.01 | -0.09, P = 0.23 | 0.39, P < 0.001 | -0.07, P = 0.53 |
Lobular inflammation | 0.31, P < 0.001 | 0.28, P < 0.001 | 0.16, P < 0.01 | 0.15, P = 0.10 | 0.26, P < 0.01 | 0.16, P = 0.15 |
Ballooning | 0.39, P < 0.001 | 0.29, P < 0.001 | 0.32, P < 0.01 | 0.29, P < 0.01 | 0.33, P < 0.001 | 0.34, P < 0.001 |
NAS | 0.58, P < 0.001 | 0.64, P < 0.001 | 0.06, P = 0.44 | 0.13, P = 0.13 | 0.49, P < 0.001 | 0.16, P = 0.13 |
P < 0.05: Correlations with statistical significance. MRE: Magnetic resonance elastography; CAP: Controlled-attenuation parameter; VCTE: Vibration-controlled transient elastography; cT1: Corrected T1; SWE: Shear-Wave elastography; NASH: Non-alcoholic steatohepatitis; LSM: Liver stiffness measure.